Thalidomide Analog [EPC]

Thalidomide Analog [EPC] was reported 522360 times

Drugs of the Thalidomide Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HUMAN CHORIONIC GONADOTROPIN INCREASED 699 0.7724
1 MONOCLONAL IMMUNOGLOBULIN INCREASED 188 0.6573
2 PLASMA CELL MYELOMA RECURRENT 2083 0.6407
3 PLASMA CELL LEUKAEMIA 381 0.6350
4 PLASMA CELL MYELOMA 24044 0.6156
5 MONOCLONAL IMMUNOGLOBULIN PRESENT 458 0.6026
6 LIGHT CHAIN ANALYSIS INCREASED 621 0.6012
7 PLASMA CELL MYELOMA REFRACTORY 752 0.5620
8 PLASMACYTOMA 951 0.5105
9 MULTIPLE MYELOMA 2368 0.5076
10 LIGHT CHAIN ANALYSIS ABNORMAL 104 0.5000
11 B-CELL TYPE ACUTE LEUKAEMIA 332 0.4523
12 FULL BLOOD COUNT DECREASED 8831 0.4378
13 FULL BLOOD COUNT INCREASED 429 0.3602
14 TUMOUR FLARE 239 0.3499
15 PARAPROTEINAEMIA 106 0.3419
16 MYELODYSPLASTIC SYNDROME TRANSFORMATION 152 0.2917
17 LABORATORY TEST ABNORMAL 5788 0.1959
18 PROTEIN TOTAL INCREASED 502 0.1884
19 AMYLOIDOSIS 315 0.1825
20 OSTEOLYSIS 365 0.1784
21 MANTLE CELL LYMPHOMA 269 0.1766
22 BLOOD IMMUNOGLOBULIN A INCREASED 95 0.1763
23 PRODUCT DISTRIBUTION ISSUE 1612 0.1736
24 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 142 0.1684
25 ACUTE LYMPHOCYTIC LEUKAEMIA 437 0.1542
26 NEUROPATHY PERIPHERAL 14665 0.1540
27 MYELODYSPLASTIC SYNDROME 2226 0.1538
28 BONE LESION 547 0.1515
29 PNEUMONIA INFLUENZAL 180 0.1511
30 CYTOPENIA 1829 0.1492
31 CARDIAC AMYLOIDOSIS 163 0.1480
32 WHITE BLOOD CELL COUNT DECREASED 15499 0.1428
33 FOLLICULAR LYMPHOMA 124 0.1409
34 SQUAMOUS CELL CARCINOMA OF SKIN 825 0.1365
35 BLOOD IMMUNOGLOBULIN G INCREASED 155 0.1275
36 LACTOSE INTOLERANCE 326 0.1271
37 DIFFUSE LARGE B-CELL LYMPHOMA 970 0.1258
38 STEM CELL TRANSPLANT 312 0.1248
39 PARAINFLUENZAE VIRUS INFECTION 188 0.1234
40 PULMONARY THROMBOSIS 1281 0.1174
41 TREATMENT DELAYED 199 0.1150
42 FEBRILE INFECTION 134 0.1138
43 ADENOCARCINOMA OF COLON 212 0.1131
44 ACUTE LEUKAEMIA 177 0.1095
45 THROMBOSIS 8792 0.1092
46 PLATELET COUNT DECREASED 11246 0.1054
47 NEUTROPHIL COUNT DECREASED 4264 0.1045
48 WHITE BLOOD CELL DISORDER 275 0.1027
49 PROTEIN TOTAL ABNORMAL 133 0.1022
50 TOOTH DISORDER 2250 0.1011
51 RED BLOOD CELL COUNT DECREASED 2842 0.0993
52 PATHOLOGICAL FRACTURE 489 0.0963
53 PNEUMONIA PNEUMOCOCCAL 141 0.0951
54 HORDEOLUM 407 0.0940
55 NEUTROPHIL COUNT ABNORMAL 265 0.0937
56 BLOOD ELECTROLYTES DECREASED 132 0.0928
57 NEUTROPENIA 12545 0.0922
58 COVID-19 PNEUMONIA 1025 0.0867
59 ACUTE MYELOID LEUKAEMIA 1328 0.0851
60 FULL BLOOD COUNT ABNORMAL 900 0.0850
61 BLOOD TEST ABNORMAL 1183 0.0841
62 MULTIPLE ALLERGIES 653 0.0832
63 BLOOD POTASSIUM DECREASED 2481 0.0824
64 RED BLOOD CELL COUNT ABNORMAL 121 0.0823
65 HYPERCALCAEMIA 1012 0.0819
66 PANCYTOPENIA 4560 0.0815
67 COMPRESSION FRACTURE 429 0.0800
68 WHITE BLOOD CELL COUNT ABNORMAL 506 0.0792
69 PLATELET DISORDER 198 0.0784
70 PNEUMONIA 25032 0.0772
71 BLOOD COUNT ABNORMAL 1171 0.0772
72 DEEP VEIN THROMBOSIS 5013 0.0771
73 STERNAL FRACTURE 95 0.0770
74 PULMONARY SEPSIS 112 0.0770
75 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 167 0.0757
76 HICCUPS 620 0.0755
77 IMMUNOGLOBULINS DECREASED 103 0.0750
78 PNEUMONIA LEGIONELLA 120 0.0749
79 RESPIRATORY SYNCYTIAL VIRUS INFECTION 650 0.0746
80 TASTE DISORDER 1490 0.0734
81 HYPOGEUSIA 143 0.0729
82 CANCER PAIN 186 0.0727
83 SALMONELLOSIS 121 0.0717
84 AGEUSIA 1775 0.0711
85 VITAMIN B12 DECREASED 204 0.0707
86 THROMBOCYTOPENIA 7764 0.0694
87 BLOOD MAGNESIUM DECREASED 598 0.0692
88 SEASONAL ALLERGY 977 0.0690
89 PNEUMONIA VIRAL 220 0.0689
90 PRODUCT SUPPLY ISSUE 476 0.0666
91 PRODUCT PRESCRIBING ISSUE 1449 0.0664
92 THERAPY INTERRUPTED 4752 0.0664
93 APPENDIX DISORDER 94 0.0663
94 PERIPHERAL SENSORY NEUROPATHY 384 0.0656
95 CORONAVIRUS INFECTION 434 0.0656
96 SPINAL COMPRESSION FRACTURE 541 0.0654
97 BONE MARROW DISORDER 192 0.0635
98 BLOOD CALCIUM DECREASED 714 0.0634
99 THROMBOPHLEBITIS SUPERFICIAL 192 0.0633
100 NEUTROPENIC SEPSIS 451 0.0631
101 CONSTIPATION 13756 0.0630
102 RESPIRATORY TRACT INFECTION VIRAL 144 0.0618
103 B-CELL LYMPHOMA 210 0.0618
104 JC VIRUS INFECTION 98 0.0612
105 FAILURE TO THRIVE 316 0.0608
106 BLOOD CALCIUM ABNORMAL 101 0.0607
107 NEOPLASM SKIN 94 0.0605
108 RHINOVIRUS INFECTION 235 0.0603
109 TUMOUR LYSIS SYNDROME 531 0.0603
110 UNEVALUABLE EVENT 4553 0.0601
111 HAEMOGLOBIN DECREASED 6172 0.0600
112 PROTEIN TOTAL DECREASED 225 0.0597
113 RENAL DISORDER 2782 0.0596
114 SPINAL CORD COMPRESSION 231 0.0593
115 BACK DISORDER 947 0.0582
116 BODY HEIGHT DECREASED 621 0.0580
117 ORAL INFECTION 226 0.0578
118 HYPOGAMMAGLOBULINAEMIA 378 0.0575
119 GOUT 1019 0.0567
120 BASAL CELL CARCINOMA 883 0.0565
121 PSEUDOMONAL SEPSIS 99 0.0565
122 PERIPHERAL SWELLING 8709 0.0565
123 HAEMATOLOGICAL INFECTION 138 0.0564
124 ADVERSE DRUG REACTION 5054 0.0562
125 RASH PRURITIC 3041 0.0561
126 CLOSTRIDIUM DIFFICILE COLITIS 593 0.0559
127 ESCHERICHIA SEPSIS 162 0.0558
128 SPINAL FRACTURE 1111 0.0554
129 ATRIAL FLUTTER 441 0.0552
130 DIARRHOEA 35568 0.0550
131 UTERINE DISORDER 127 0.0545
132 DIVERTICULAR PERFORATION 112 0.0544
133 THERAPY PARTIAL RESPONDER 832 0.0533
134 BLOOD POTASSIUM ABNORMAL 141 0.0528
135 IMMUNE SYSTEM DISORDER 693 0.0525
136 BLOOD CALCIUM INCREASED 459 0.0523
137 CLAVICLE FRACTURE 199 0.0519
138 LOBAR PNEUMONIA 96 0.0518
139 LUNG ADENOCARCINOMA 156 0.0518
140 HAEMATOTOXICITY 489 0.0514
141 CLOSTRIDIUM DIFFICILE INFECTION 1116 0.0511
142 MUSCLE SPASMS 9346 0.0509
143 POLYNEUROPATHY 608 0.0507
144 TOOTH INFECTION 669 0.0507
145 HIP FRACTURE 1621 0.0504
146 SPINAL DISORDER 476 0.0502
147 LOCALISED INFECTION 1210 0.0500
148 BLOOD DISORDER 397 0.0495
149 PNEUMONIA FUNGAL 195 0.0494
150 RASH 21380 0.0490
151 GALLBLADDER DISORDER 875 0.0490
152 VIRAL UPPER RESPIRATORY TRACT INFECTION 233 0.0490
153 ORAL DISORDER 358 0.0488
154 ATYPICAL PNEUMONIA 146 0.0488
155 SEPSIS 5432 0.0487
156 ESCHERICHIA BACTERAEMIA 114 0.0484
157 LYMPHOMA 746 0.0482
158 EXPOSED BONE IN JAW 104 0.0479
159 RIB FRACTURE 982 0.0477
160 PLATELET COUNT ABNORMAL 288 0.0476
161 RESPIRATORY TRACT INFECTION 1236 0.0474
162 COVID-19 8315 0.0473
163 EAR SWELLING 100 0.0472
164 CHRONIC LYMPHOCYTIC LEUKAEMIA 224 0.0472
165 ANAEMIA 9001 0.0471
166 FEBRILE NEUTROPENIA 3129 0.0471
167 UPPER RESPIRATORY TRACT INFECTION 2155 0.0466
168 BLOOD IMMUNOGLOBULIN G DECREASED 115 0.0464
169 ATRIAL FIBRILLATION 4491 0.0461
170 PULMONARY EMBOLISM 4378 0.0460
171 MUSCULOSKELETAL CHEST PAIN 707 0.0456
172 VENOUS THROMBOSIS LIMB 94 0.0455
173 SARS-COV-2 TEST POSITIVE 601 0.0455
174 PERFORMANCE STATUS DECREASED 211 0.0452
175 VENOUS THROMBOSIS 174 0.0443
176 HUMERUS FRACTURE 213 0.0441
177 BLOOD IRON DECREASED 523 0.0440
178 FATIGUE 34282 0.0440
179 DRUG INTOLERANCE 4247 0.0439
180 NO THERAPEUTIC RESPONSE 536 0.0439
181 GINGIVITIS 237 0.0439
182 INCREASED TENDENCY TO BRUISE 404 0.0439
183 INFLUENZA 4862 0.0436
184 BRONCHITIS 3217 0.0434
185 EMBOLISM VENOUS 130 0.0428
186 SQUAMOUS CELL CARCINOMA 403 0.0428
187 BONE MARROW FAILURE 865 0.0425
188 INFECTION 6160 0.0425
189 ADVERSE EVENT 3910 0.0424
190 BACTERAEMIA 502 0.0423
191 HERPES ZOSTER 2424 0.0421
192 DISEASE COMPLICATION 193 0.0421
193 PRODUCT DOSE OMISSION ISSUE 12356 0.0420
194 GASTROINTESTINAL MOTILITY DISORDER 224 0.0418
195 CATARACT 2485 0.0417
196 LUMBAR VERTEBRAL FRACTURE 191 0.0416
197 INSURANCE ISSUE 635 0.0415
198 BACTERIAL SEPSIS 134 0.0411
199 EYE INFECTION 462 0.0409
200 SKIN DISCOLOURATION 1878 0.0408
201 EXFOLIATIVE RASH 107 0.0406
202 DISEASE PROGRESSION 4784 0.0404
203 CHOLECYSTITIS INFECTIVE 112 0.0403
204 CERVICAL VERTEBRAL FRACTURE 139 0.0402
205 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 331 0.0401
206 DIVERTICULITIS 1108 0.0399
207 OSTEONECROSIS OF JAW 989 0.0399
208 PRODUCT ADMINISTRATION INTERRUPTED 313 0.0398
209 EMBOLISM 331 0.0398
210 DEATH 34106 0.0395
211 PROSTATIC DISORDER 218 0.0395
212 DEHYDRATION 5267 0.0394
213 PELVIC FRACTURE 307 0.0394
214 CYTOMEGALOVIRUS INFECTION REACTIVATION 173 0.0391
215 BLOOD CREATININE ABNORMAL 135 0.0390
216 GASTRIC INFECTION 149 0.0389
217 CELLULITIS 1952 0.0387
218 CARDIAC DISORDER 3620 0.0387
219 MALIGNANT MELANOMA 518 0.0386
220 SECOND PRIMARY MALIGNANCY 320 0.0384
221 METABOLIC ENCEPHALOPATHY 114 0.0379
222 HAEMOGLOBIN ABNORMAL 244 0.0379
223 THERAPY CHANGE 372 0.0378
224 FOOD POISONING 202 0.0377
225 PNEUMONIA BACTERIAL 345 0.0375
226 URINARY TRACT INFECTION 6410 0.0375
227 SEPTIC SHOCK 1635 0.0375
228 LEUKAEMIA 354 0.0375
229 UPPER LIMB FRACTURE 745 0.0374
230 SINUS DISORDER 736 0.0371
231 CYTOKINE RELEASE SYNDROME 745 0.0371
232 BONE DISORDER 675 0.0370
233 ESCHERICHIA URINARY TRACT INFECTION 157 0.0369
234 CARDIAC VALVE DISEASE 211 0.0369
235 GASTROINTESTINAL INFECTION 330 0.0368
236 PAPULE 258 0.0366
237 RENAL FUNCTION TEST ABNORMAL 170 0.0366
238 DERMATITIS EXFOLIATIVE GENERALISED 126 0.0362
239 BONE PAIN 2120 0.0362
240 THORACIC VERTEBRAL FRACTURE 107 0.0361
241 VITAMIN D DECREASED 309 0.0361
242 RENAL IMPAIRMENT 3023 0.0359
243 HEARING IMPAIRED 215 0.0358
244 RESPIRATORY TRACT CONGESTION 568 0.0357
245 ARTHROPATHY 1985 0.0357
246 NASOPHARYNGITIS 6575 0.0356
247 UROSEPSIS 329 0.0356
248 LYMPHOPENIA 502 0.0355
249 DEMENTIA 990 0.0354
250 FRACTURE 670 0.0354
251 LEUKOPENIA 1769 0.0353
252 RENAL FAILURE 4681 0.0352
253 SKIN CANCER 758 0.0352
254 ARTHRITIS INFECTIVE 163 0.0351
255 PRODUCT DISPENSING ISSUE 149 0.0348
256 BLOOD PHOSPHORUS DECREASED 127 0.0347
257 PRODUCT DOSE OMISSION IN ERROR 982 0.0346
258 HEPATITIS B REACTIVATION 110 0.0346
259 NAIL DISCOLOURATION 136 0.0346
260 STAPHYLOCOCCAL BACTERAEMIA 149 0.0342
261 GASTRIC DISORDER 1175 0.0342
262 GASTROINTESTINAL TOXICITY 164 0.0341
263 HYPOCALCAEMIA 646 0.0341
264 GINGIVAL PAIN 271 0.0340
265 ASTHENIA 12798 0.0340
266 NEOPLASM 391 0.0340
267 PROSTATOMEGALY 133 0.0338
268 LUNG INFECTION 523 0.0336
269 VIRAL INFECTION 1120 0.0336
270 GINGIVAL DISORDER 129 0.0335
271 FEBRILE BONE MARROW APLASIA 142 0.0334
272 THROMBOPHLEBITIS 117 0.0333
273 MUSCLE STRAIN 288 0.0333
274 IMMUNODEFICIENCY 490 0.0328
275 HERNIA 632 0.0327
276 JAW DISORDER 178 0.0325
277 BRAIN FOG 509 0.0324
278 GRAFT VERSUS HOST DISEASE 232 0.0322
279 NEURALGIA 784 0.0322
280 CREATININE RENAL CLEARANCE DECREASED 129 0.0322
281 PIGMENTATION DISORDER 199 0.0322
282 OSTEOMYELITIS 582 0.0321
283 RASH GENERALISED 832 0.0321
284 OEDEMA PERIPHERAL 3889 0.0319
285 IMMUNOSUPPRESSION 281 0.0318
286 ELECTROLYTE IMBALANCE 365 0.0314
287 DECUBITUS ULCER 256 0.0314
288 NERVE INJURY 349 0.0314
289 GASTROENTERITIS VIRAL 566 0.0313
290 APPETITE DISORDER 206 0.0310
291 TOOTH ABSCESS 315 0.0309
292 INTENTIONAL PRODUCT USE ISSUE 2707 0.0309
293 FLUID RETENTION 1553 0.0305
294 CARDIAC FAILURE CONGESTIVE 2452 0.0305
295 DECREASED APPETITE 7081 0.0305
296 RASH MACULO-PAPULAR 678 0.0304
297 STAPHYLOCOCCAL SEPSIS 150 0.0304
298 SINUSITIS 3106 0.0303
299 LOOSE TOOTH 97 0.0301
300 HYPOAESTHESIA 4498 0.0300
301 ESCHERICHIA INFECTION 247 0.0300
302 PNEUMOCYSTIS JIROVECII PNEUMONIA 301 0.0299
303 MENINGITIS 198 0.0296
304 BACK PAIN 6866 0.0295
305 THROMBOTIC THROMBOCYTOPENIC PURPURA 104 0.0295
306 TRANSIENT ISCHAEMIC ATTACK 993 0.0294
307 HAEMORRHOIDAL HAEMORRHAGE 143 0.0293
308 BLOOD PRESSURE ABNORMAL 582 0.0292
309 NIGHT SWEATS 938 0.0291
310 HYPOACUSIS 1253 0.0291
311 GINGIVAL SWELLING 128 0.0290
312 ORAL PAIN 647 0.0289
313 RASH VESICULAR 139 0.0287
314 BOWEL MOVEMENT IRREGULARITY 220 0.0287
315 AORTIC STENOSIS 99 0.0284
316 COLITIS ISCHAEMIC 191 0.0283
317 GASTROINTESTINAL DISORDER 2530 0.0282
318 JOINT SWELLING 3392 0.0281
319 FALL 9282 0.0279
320 BACTERIAL INFECTION 515 0.0276
321 LARGE INTESTINE PERFORATION 191 0.0275
322 HYPOPHOSPHATAEMIA 203 0.0274
323 HYPERURICAEMIA 112 0.0272
324 PHLEBITIS 139 0.0271
325 RESPIRATION ABNORMAL 187 0.0271
326 BRONCHOPULMONARY ASPERGILLOSIS 210 0.0271
327 ARTHRITIS BACTERIAL 111 0.0270
328 PULMONARY OEDEMA 1210 0.0270
329 ACUTE RESPIRATORY FAILURE 517 0.0268
330 PERIPHERAL COLDNESS 369 0.0268
331 PRODUCT DOSE OMISSION 1750 0.0268
332 LOWER LIMB FRACTURE 514 0.0267
333 MYELOSUPPRESSION 961 0.0267
334 OFF LABEL USE 23303 0.0266
335 CYSTITIS 845 0.0265
336 HOSPITALISATION 4073 0.0265
337 THROMBOTIC MICROANGIOPATHY 258 0.0264
338 DERMATITIS ALLERGIC 333 0.0264
339 FAECALOMA 145 0.0264
340 ARTHROPOD BITE 196 0.0264
341 ORTHOSTATIC HYPOTENSION 459 0.0263
342 UPPER-AIRWAY COUGH SYNDROME 217 0.0263
343 PYREXIA 9108 0.0263
344 HYPOKALAEMIA 1214 0.0263
345 FURUNCLE 208 0.0262
346 TOOTHACHE 473 0.0261
347 SKIN INFECTION 292 0.0260
348 SKIN TOXICITY 147 0.0260
349 ILLNESS 2671 0.0259
350 EAR DISORDER 118 0.0257
351 FUNGAL SKIN INFECTION 104 0.0257
352 FAECES HARD 100 0.0257
353 ANGIOPATHY 144 0.0257
354 POOR PERIPHERAL CIRCULATION 109 0.0256
355 MASS 356 0.0254
356 SWELLING FACE 1655 0.0254
357 EYE DISORDER 832 0.0253
358 BLOOD CREATINE INCREASED 112 0.0253
359 COLITIS 958 0.0252
360 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 96 0.0251
361 TUMOUR MARKER INCREASED 120 0.0250
362 MUSCULOSKELETAL DISORDER 475 0.0249
363 COLON CANCER 368 0.0247
364 GUILLAIN-BARRE SYNDROME 119 0.0246
365 STOMATITIS 1487 0.0245
366 KIDNEY INFECTION 481 0.0245
367 BALANCE DISORDER 2113 0.0244
368 RASH MACULAR 854 0.0244
369 GINGIVAL BLEEDING 331 0.0242
370 CONTUSION 2327 0.0241
371 OEDEMA 1310 0.0241
372 CARDIAC FAILURE 1936 0.0241
373 HAEMATOCRIT DECREASED 474 0.0239
374 BLOOD CREATININE INCREASED 1556 0.0238
375 ONYCHOCLASIS 164 0.0238
376 CHOLECYSTITIS ACUTE 135 0.0238
377 LIMB DISCOMFORT 736 0.0238
378 RHINORRHOEA 1534 0.0237
379 LYMPHOEDEMA 164 0.0237
380 MENTAL STATUS CHANGES 656 0.0236
381 RENAL FAILURE CHRONIC 180 0.0234
382 TREMOR 3884 0.0234
383 PRURITUS 8989 0.0234
384 LIMB INJURY 633 0.0233
385 RECURRENT CANCER 95 0.0233
386 HYPOALBUMINAEMIA 181 0.0233
387 HYPERVOLAEMIA 115 0.0232
388 TOXIC SKIN ERUPTION 234 0.0232
389 TREATMENT NONCOMPLIANCE 1271 0.0232
390 SPINAL PAIN 272 0.0232
391 PNEUMONITIS 632 0.0232
392 INGUINAL HERNIA 141 0.0232
393 CANDIDA INFECTION 390 0.0231
394 LYMPHOCYTE COUNT DECREASED 408 0.0231
395 CYST 286 0.0230
396 SKIN ATROPHY 132 0.0229
397 ADVERSE REACTION 304 0.0229
398 SCIATICA 365 0.0229
399 PLEURAL EFFUSION 1389 0.0228
400 RESPIRATORY FAILURE 1659 0.0227
401 APPENDICITIS 211 0.0226
402 EAR INFECTION 601 0.0226
403 MELANOCYTIC NAEVUS 99 0.0226
404 BLADDER DISORDER 224 0.0225
405 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 580 0.0225
406 LOWER RESPIRATORY TRACT INFECTION 1025 0.0225
407 PARAESTHESIA 3541 0.0225
408 DEAFNESS 588 0.0225
409 FEELING JITTERY 428 0.0224
410 DYSPHONIA 1311 0.0224
411 HYPERSOMNIA 638 0.0222
412 SKIN DISORDER 739 0.0221
413 BONE CANCER 96 0.0221
414 HYPOTENSION 4393 0.0219
415 RESPIRATORY DISORDER 654 0.0218
416 HEPATITIS B 131 0.0217
417 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1130 0.0216
418 MULTIPLE ORGAN DYSFUNCTION SYNDROME 613 0.0216
419 WEIGHT FLUCTUATION 226 0.0216
420 DYSGEUSIA 1603 0.0216
421 ACUTE PULMONARY OEDEMA 121 0.0215
422 SKIN LESION 583 0.0212
423 EPISTAXIS 1586 0.0212
424 CARDIAC FAILURE ACUTE 141 0.0211
425 BLOOD SODIUM DECREASED 399 0.0211
426 ILEUS 263 0.0211
427 SKIN ABRASION 100 0.0211
428 ENTEROCOLITIS 122 0.0211
429 VARICOSE VEIN 109 0.0211
430 HYPOAESTHESIA ORAL 318 0.0211
431 HAEMORRHOIDS 411 0.0210
432 SKIN ULCER 544 0.0210
433 SYNCOPE 2095 0.0209
434 MALNUTRITION 234 0.0209
435 CEREBROVASCULAR ACCIDENT 3535 0.0208
436 THERAPY NON-RESPONDER 938 0.0208
437 HOSPICE CARE 206 0.0208
438 TROPONIN INCREASED 158 0.0207
439 BLOOD URINE PRESENT 394 0.0207
440 FEMUR FRACTURE 641 0.0207
441 SWELLING 1936 0.0207
442 ENDOCARDITIS 106 0.0206
443 HEPATIC ENZYME ABNORMAL 103 0.0206
444 FLATULENCE 1171 0.0206
445 ACUTE CORONARY SYNDROME 171 0.0206
446 SMALL INTESTINAL OBSTRUCTION 254 0.0206
447 ACUTE MYOCARDIAL INFARCTION 608 0.0206
448 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 122 0.0206
449 ATELECTASIS 199 0.0206
450 MEMORY IMPAIRMENT 2827 0.0206
451 SUDDEN DEATH 216 0.0204
452 DRY SKIN 2720 0.0204
453 NERVE COMPRESSION 187 0.0202
454 WEIGHT DECREASED 5653 0.0202
455 STAPHYLOCOCCAL INFECTION 667 0.0202
456 FAECES SOFT 147 0.0202
457 DRUG ERUPTION 357 0.0201
458 HYPOPHAGIA 515 0.0201
459 CHOLECYSTITIS 239 0.0200
460 SKIN HYPERPIGMENTATION 172 0.0200
461 DIVERTICULUM 142 0.0200
462 COUGH 5594 0.0199
463 MALIGNANT NEOPLASM PROGRESSION 2042 0.0199
464 ABDOMINAL DISCOMFORT 3338 0.0199
465 NEPHROPATHY 185 0.0198
466 HEART RATE DECREASED 694 0.0197
467 LUNG INFILTRATION 174 0.0197
468 CYTOMEGALOVIRUS INFECTION 327 0.0197
469 INTESTINAL OBSTRUCTION 738 0.0196
470 COGNITIVE DISORDER 914 0.0196
471 SPLENOMEGALY 229 0.0195
472 FEMORAL NECK FRACTURE 100 0.0195
473 GASTROENTERITIS 283 0.0194
474 ORGANISING PNEUMONIA 96 0.0194
475 APHONIA 270 0.0193
476 ACUTE KIDNEY INJURY 2947 0.0192
477 EYE SWELLING 716 0.0192
478 CONFUSIONAL STATE 3105 0.0192
479 PULMONARY MASS 286 0.0192
480 DIZZINESS POSTURAL 186 0.0192
481 DEVICE RELATED INFECTION 295 0.0191
482 ISCHAEMIC STROKE 342 0.0191
483 DIZZINESS 9528 0.0191
484 BLOOD POTASSIUM INCREASED 310 0.0191
485 SKIN LACERATION 207 0.0190
486 HEAD INJURY 601 0.0190
487 GENERALISED OEDEMA 234 0.0189
488 HEART RATE IRREGULAR 427 0.0189
489 AMNESIA 1227 0.0188
490 PERIPHERAL VASCULAR DISORDER 97 0.0188
491 ATRIOVENTRICULAR BLOCK 145 0.0187
492 THYROID DISORDER 289 0.0187
493 WOUND INFECTION 205 0.0187
494 PETECHIAE 195 0.0187
495 EAR DISCOMFORT 191 0.0186
496 TOOTH FRACTURE 205 0.0186
497 EOSINOPHILIA 324 0.0185
498 DYSPNOEA 10441 0.0184
499 SLUGGISHNESS 188 0.0184
500 RENAL FAILURE ACUTE 782 0.0184
501 LUNG DISORDER 901 0.0184
502 INCONTINENCE 194 0.0183
503 HYPERGLYCAEMIA 667 0.0183
504 SENSITIVE SKIN 135 0.0183
505 TOXICITY TO VARIOUS AGENTS 3080 0.0182
506 PHARYNGITIS 226 0.0182
507 PERICARDIAL EFFUSION 421 0.0182
508 BENIGN PROSTATIC HYPERPLASIA 94 0.0182
509 FEEDING DISORDER 369 0.0182
510 INSOMNIA 4842 0.0182
511 SINUS CONGESTION 245 0.0181
512 DENTAL CARIES 200 0.0181
513 ORAL CANDIDIASIS 238 0.0181
514 DYSPNOEA EXERTIONAL 680 0.0180
515 POLLAKIURIA 746 0.0179
516 BACK INJURY 194 0.0178
517 GENERAL PHYSICAL CONDITION ABNORMAL 120 0.0177
518 CARDIAC FLUTTER 114 0.0176
519 HYPOXIA 620 0.0176
520 SUBDURAL HAEMATOMA 252 0.0176
521 HEART RATE ABNORMAL 98 0.0176
522 LETHARGY 1009 0.0175
523 PLEURISY 104 0.0175
524 PAROSMIA 132 0.0175
525 RASH ERYTHEMATOUS 836 0.0175
526 NEPHROLITHIASIS 800 0.0174
527 LIVER FUNCTION TEST INCREASED 374 0.0174
528 DRY EYE 869 0.0174
529 PERIORBITAL SWELLING 98 0.0173
530 CEREBRAL DISORDER 128 0.0173
531 HYPOVOLAEMIA 101 0.0172
532 HYPOMAGNESAEMIA 240 0.0172
533 PURPURA 152 0.0172
534 SKIN REACTION 241 0.0171
535 ASPERGILLUS INFECTION 112 0.0170
536 MUCOSAL INFLAMMATION 446 0.0170
537 NAUSEA 13397 0.0169
538 EATING DISORDER 360 0.0169
539 ROTATOR CUFF SYNDROME 217 0.0169
540 INTERNAL HAEMORRHAGE 193 0.0169
541 SKIN EXFOLIATION 1425 0.0169
542 PAIN IN EXTREMITY 4970 0.0169
543 GAIT INABILITY 563 0.0168
544 ABDOMINAL PAIN UPPER 3462 0.0168
545 PRODUCTIVE COUGH 802 0.0168
546 LIVER DISORDER 744 0.0168
547 OROPHARYNGEAL PAIN 1540 0.0166
548 FOOT FRACTURE 315 0.0166
549 MULTI-ORGAN FAILURE 287 0.0166
550 ANOSMIA 240 0.0166
551 MACULAR DEGENERATION 197 0.0165
552 URINE ODOUR ABNORMAL 97 0.0165
553 POST PROCEDURAL INFECTION 134 0.0165
554 BLOOD URIC ACID INCREASED 95 0.0164
555 DIARRHOEA HAEMORRHAGIC 153 0.0164
556 HAIR GROWTH ABNORMAL 113 0.0163
557 SWELLING OF EYELID 102 0.0162
558 INTESTINAL PERFORATION 182 0.0162
559 LYMPHADENOPATHY 572 0.0161
560 VISION BLURRED 2214 0.0161
561 ARRHYTHMIA 763 0.0161
562 LACRIMATION INCREASED 483 0.0160
563 WOUND 446 0.0159
564 DRY MOUTH 1289 0.0159
565 BODY TEMPERATURE INCREASED 323 0.0158
566 FUNGAL INFECTION 527 0.0158
567 NECK PAIN 883 0.0158
568 DYSPEPSIA 1552 0.0158
569 INFUSION RELATED REACTION 1039 0.0157
570 NEOPLASM PROGRESSION 545 0.0157
571 URINE OUTPUT DECREASED 136 0.0155
572 PULMONARY TOXICITY 110 0.0155
573 GASTROINTESTINAL PAIN 171 0.0155
574 GLAUCOMA 299 0.0155
575 LACERATION 146 0.0155
576 ANKLE FRACTURE 240 0.0155
577 RHINITIS 125 0.0155
578 ABDOMINAL DISTENSION 1617 0.0155
579 EAR PAIN 301 0.0155
580 PNEUMONIA ASPIRATION 386 0.0154
581 GENERAL PHYSICAL HEALTH DETERIORATION 1786 0.0154
582 CHEST PAIN 2852 0.0154
583 MUSCULAR WEAKNESS 1749 0.0154
584 LIGAMENT SPRAIN 152 0.0154
585 CHOLELITHIASIS 504 0.0154
586 PAIN IN JAW 433 0.0153
587 FLUID OVERLOAD 222 0.0152
588 DRY THROAT 155 0.0152
589 EYE DISCHARGE 158 0.0152
590 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 118 0.0152
591 TENDERNESS 158 0.0151
592 LOCAL SWELLING 264 0.0151
593 MALAISE 6630 0.0151
594 WRIST FRACTURE 181 0.0151
595 CARDIOMYOPATHY 223 0.0151
596 INTERVERTEBRAL DISC DEGENERATION 139 0.0150
597 SUNBURN 112 0.0150
598 CHILLS 1760 0.0150
599 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 143 0.0150
600 MYOCARDIAL INFARCTION 2610 0.0149
601 ULCER 238 0.0149
602 BLOOD LACTATE DEHYDROGENASE INCREASED 237 0.0149
603 ULCER HAEMORRHAGE 101 0.0149
604 BLOOD TESTOSTERONE DECREASED 102 0.0149
605 DYSURIA 546 0.0148
606 SUPRAVENTRICULAR TACHYCARDIA 142 0.0148
607 PLATELET COUNT INCREASED 193 0.0148
608 CARDIOTOXICITY 132 0.0148
609 HAEMOLYTIC ANAEMIA 132 0.0147
610 ACUTE RESPIRATORY DISTRESS SYNDROME 260 0.0147
611 SKIN MASS 98 0.0147
612 FAECES DISCOLOURED 318 0.0147
613 JOINT INJURY 313 0.0146
614 BLOOD ALBUMIN DECREASED 116 0.0146
615 FLANK PAIN 137 0.0146
616 URTICARIA 2442 0.0146
617 BLISTER 818 0.0146
618 LOSS OF CONSCIOUSNESS 1860 0.0145
619 MUSCLE TIGHTNESS 235 0.0145
620 TINNITUS 663 0.0144
621 HYPERTHERMIA 110 0.0144
622 INCREASED APPETITE 275 0.0144
623 ARTHRITIS 1130 0.0144
624 URINARY RETENTION 479 0.0143
625 TRICUSPID VALVE INCOMPETENCE 114 0.0143
626 SPINAL OSTEOARTHRITIS 126 0.0143
627 NOCTURIA 173 0.0142
628 NERVOUSNESS 743 0.0142
629 PRESYNCOPE 345 0.0142
630 ECCHYMOSIS 97 0.0141
631 HEPATIC ENZYME INCREASED 963 0.0141
632 GROIN PAIN 124 0.0141
633 ACCIDENT 168 0.0141
634 AORTIC ANEURYSM 107 0.0140
635 HAEMOPTYSIS 392 0.0140
636 MYOPATHY 121 0.0140
637 ANAL INCONTINENCE 126 0.0140
638 C-REACTIVE PROTEIN INCREASED 505 0.0139
639 PHARYNGITIS STREPTOCOCCAL 150 0.0138
640 CONJUNCTIVITIS 257 0.0138
641 MITRAL VALVE INCOMPETENCE 156 0.0138
642 MOUTH HAEMORRHAGE 101 0.0138
643 BURSITIS 167 0.0138
644 EMPHYSEMA 138 0.0137
645 CARDIAC ARREST 1126 0.0136
646 HYPERSENSITIVITY 2526 0.0136
647 FEELING ABNORMAL 3247 0.0135
648 PRODUCT PHYSICAL ISSUE 272 0.0135
649 NEUROTOXICITY 235 0.0134
650 RASH PAPULAR 300 0.0134
651 PRODUCT DISPENSING ERROR 290 0.0133
652 PULMONARY HAEMORRHAGE 104 0.0133
653 PARAESTHESIA ORAL 191 0.0132
654 POOR QUALITY SLEEP 285 0.0132
655 RENAL CYST 105 0.0132
656 IRRITABLE BOWEL SYNDROME 283 0.0132
657 INABILITY TO AFFORD MEDICATION 131 0.0132
658 CEREBRAL HAEMORRHAGE 472 0.0132
659 NASAL CONGESTION 774 0.0132
660 CORONARY ARTERY DISEASE 398 0.0131
661 DELIRIUM 455 0.0131
662 BRAIN NEOPLASM 120 0.0130
663 PULMONARY CONGESTION 172 0.0130
664 NAIL DISORDER 114 0.0130
665 FACIAL PARALYSIS 111 0.0130
666 INTENTIONAL DOSE OMISSION 369 0.0129
667 CARDIOMEGALY 159 0.0129
668 DIABETES MELLITUS 981 0.0129
669 MUSCULOSKELETAL DISCOMFORT 221 0.0128
670 DECREASED IMMUNE RESPONSIVENESS 126 0.0128
671 ABSCESS 204 0.0128
672 VOMITING 6010 0.0128
673 BLOOD BILIRUBIN INCREASED 345 0.0128
674 GASTROOESOPHAGEAL REFLUX DISEASE 1027 0.0127
675 RENAL PAIN 135 0.0127
676 BURNING SENSATION 893 0.0127
677 PSEUDOMONAS INFECTION 109 0.0127
678 EXOSTOSIS 116 0.0127
679 RECTAL HAEMORRHAGE 544 0.0126
680 RESPIRATORY DISTRESS 349 0.0126
681 DYSPHAGIA 1197 0.0126
682 THERAPY CESSATION 645 0.0126
683 NEPHROPATHY TOXIC 141 0.0125
684 HAEMATOCHEZIA 692 0.0125
685 BLOOD PRESSURE DECREASED 833 0.0125
686 SOMNOLENCE 2520 0.0125
687 WHITE BLOOD CELL COUNT INCREASED 478 0.0124
688 INTERVERTEBRAL DISC PROTRUSION 272 0.0124
689 MYOCARDITIS 142 0.0124
690 APHTHOUS ULCER 96 0.0124
691 GASTRIC ULCER 235 0.0124
692 RESTLESS LEGS SYNDROME 224 0.0123
693 ABASIA 304 0.0123
694 ENCEPHALOPATHY 301 0.0122
695 PAIN 7524 0.0122
696 PULMONARY HYPERTENSION 255 0.0122
697 EYE HAEMORRHAGE 163 0.0122
698 SINUS BRADYCARDIA 118 0.0122
699 VASCULITIS 142 0.0122
700 MOUTH ULCERATION 256 0.0121
701 ARTERIOSCLEROSIS 114 0.0121
702 EJECTION FRACTION DECREASED 188 0.0121
703 HYPERBILIRUBINAEMIA 125 0.0121
704 STEVENS-JOHNSON SYNDROME 268 0.0120
705 SNEEZING 270 0.0120
706 GASTROINTESTINAL HAEMORRHAGE 1001 0.0120
707 HAEMORRHAGE 1250 0.0119
708 HYPERHIDROSIS 1539 0.0119
709 MYALGIA 2031 0.0119
710 DISSEMINATED INTRAVASCULAR COAGULATION 168 0.0119
711 PROSTATIC SPECIFIC ANTIGEN INCREASED 163 0.0118
712 FACE OEDEMA 199 0.0118
713 CARPAL TUNNEL SYNDROME 165 0.0118
714 PULMONARY FIBROSIS 226 0.0118
715 MUSCLE ATROPHY 149 0.0117
716 DISORIENTATION 464 0.0117
717 NERVOUS SYSTEM DISORDER 364 0.0117
718 CHROMATURIA 263 0.0116
719 GASTRITIS 305 0.0116
720 LIVER FUNCTION TEST ABNORMAL 337 0.0116
721 VERTIGO 703 0.0115
722 GAIT DISTURBANCE 2204 0.0115
723 NEOPLASM MALIGNANT 766 0.0115
724 GLOMERULAR FILTRATION RATE DECREASED 141 0.0115
725 MUSCULOSKELETAL STIFFNESS 992 0.0113
726 VITREOUS FLOATERS 111 0.0113
727 HYPONATRAEMIA 636 0.0113
728 HOT FLUSH 850 0.0113
729 HIATUS HERNIA 146 0.0113
730 FEELING COLD 312 0.0112
731 HYPERTENSION 2369 0.0112
732 QUALITY OF LIFE DECREASED 150 0.0112
733 SLEEP DISORDER 789 0.0112
734 ARTHRALGIA 4646 0.0112
735 BLOOD GLUCOSE ABNORMAL 206 0.0111
736 VISUAL IMPAIRMENT 1380 0.0111
737 DIPLOPIA 289 0.0111
738 HEAD DISCOMFORT 196 0.0111
739 JOINT DISLOCATION 117 0.0111
740 MULTIPLE FRACTURES 181 0.0110
741 DRUG DOSE OMISSION 1814 0.0110
742 URINARY INCONTINENCE 325 0.0110
743 HAEMATOMA 282 0.0109
744 SCAB 124 0.0109
745 AGRANULOCYTOSIS 202 0.0109
746 DERMATITIS 227 0.0108
747 ERYTHEMA MULTIFORME 101 0.0108
748 HEPATIC CYTOLYSIS 138 0.0108
749 MUSCULOSKELETAL PAIN 567 0.0108
750 MICTURITION URGENCY 123 0.0108
751 WEIGHT INCREASED 2408 0.0107
752 ABDOMINAL PAIN 2493 0.0107
753 SECRETION DISCHARGE 134 0.0107
754 OCULAR DISCOMFORT 120 0.0107
755 HEPATIC FUNCTION ABNORMAL 396 0.0106
756 INFLUENZA LIKE ILLNESS 868 0.0105
757 PNEUMOTHORAX 167 0.0105
758 HAEMORRHAGE INTRACRANIAL 157 0.0105
759 PRURITUS GENERALISED 227 0.0105
760 IMPAIRED HEALING 344 0.0105
761 CARDIOGENIC SHOCK 150 0.0104
762 RETINAL DETACHMENT 96 0.0104
763 DERMATITIS CONTACT 119 0.0104
764 VENTRICULAR EXTRASYSTOLES 108 0.0104
765 ROAD TRAFFIC ACCIDENT 433 0.0103
766 ADRENAL INSUFFICIENCY 125 0.0103
767 OESOPHAGITIS 112 0.0102
768 ASPIRATION 112 0.0102
769 HAEMATURIA 350 0.0102
770 TOXIC EPIDERMAL NECROLYSIS 155 0.0102
771 ALOPECIA 2003 0.0102
772 ANGINA PECTORIS 292 0.0102
773 CEREBRAL INFARCTION 247 0.0101
774 THIRST 179 0.0100
775 INTERNATIONAL NORMALISED RATIO INCREASED 284 0.0100
776 ORAL DISCOMFORT 138 0.0099
777 HYPERKALAEMIA 347 0.0099
778 ORAL HERPES 193 0.0099
779 CARDIOVASCULAR DISORDER 249 0.0098
780 VENTRICULAR TACHYCARDIA 161 0.0097
781 INTERSTITIAL LUNG DISEASE 470 0.0097
782 RENAL TUBULAR NECROSIS 95 0.0097
783 BLOOD UREA INCREASED 162 0.0097
784 APHASIA 292 0.0097
785 SKIN HAEMORRHAGE 143 0.0096
786 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 223 0.0096
787 HEPATOMEGALY 94 0.0096
788 PSYCHOMOTOR HYPERACTIVITY 157 0.0095
789 HEPATIC FAILURE 284 0.0094
790 HYPOTHYROIDISM 300 0.0094
791 CARDIO-RESPIRATORY ARREST 392 0.0094
792 HEART RATE INCREASED 928 0.0094
793 OSTEOPENIA 141 0.0093
794 OSTEOPOROSIS 381 0.0093
795 HEPATOTOXICITY 205 0.0092
796 FREQUENT BOWEL MOVEMENTS 248 0.0092
797 BRADYCARDIA 486 0.0092
798 ERYTHEMA 1881 0.0091
799 MYOCARDIAL ISCHAEMIA 104 0.0091
800 THERAPEUTIC RESPONSE DECREASED 550 0.0091
801 MOOD ALTERED 247 0.0090
802 LUNG NEOPLASM MALIGNANT 371 0.0090
803 TOOTH EXTRACTION 112 0.0090
804 OCULAR HYPERAEMIA 427 0.0090
805 PERICARDITIS 151 0.0090
806 THERAPEUTIC PRODUCT EFFECT DECREASED 402 0.0090
807 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 302 0.0089
808 ERECTILE DYSFUNCTION 229 0.0089
809 PRESCRIBED UNDERDOSE 177 0.0089
810 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1597 0.0089
811 FEELING HOT 540 0.0088
812 HYPERLIPIDAEMIA 105 0.0088
813 BLOOD PRESSURE FLUCTUATION 210 0.0087
814 PHOTOSENSITIVITY REACTION 144 0.0087
815 GASTRIC HAEMORRHAGE 100 0.0087
816 COLD SWEAT 153 0.0087
817 INFLAMMATION 445 0.0086
818 BLOOD PRESSURE INCREASED 1314 0.0086
819 GLOSSODYNIA 192 0.0086
820 CORONARY ARTERY OCCLUSION 117 0.0085
821 HEADACHE 5349 0.0085
822 NODULE 111 0.0085
823 ALANINE AMINOTRANSFERASE INCREASED 522 0.0085
824 ATAXIA 100 0.0084
825 CHEST DISCOMFORT 862 0.0084
826 LIP SWELLING 280 0.0084
827 DYSSTASIA 245 0.0084
828 TOOTH LOSS 172 0.0083
829 JAUNDICE 223 0.0083
830 EYELID OEDEMA 96 0.0083
831 BLOOD GLUCOSE DECREASED 396 0.0082
832 BLINDNESS 336 0.0082
833 SINUS TACHYCARDIA 117 0.0082
834 JOINT STIFFNESS 216 0.0082
835 PARALYSIS 117 0.0082
836 END STAGE RENAL DISEASE 149 0.0082
837 CIRCULATORY COLLAPSE 139 0.0082
838 THINKING ABNORMAL 152 0.0081
839 PRODUCT USE ISSUE 1533 0.0081
840 MENTAL IMPAIRMENT 197 0.0081
841 DIALYSIS 115 0.0081
842 OSTEONECROSIS 266 0.0081
843 BLOOD GLUCOSE INCREASED 1524 0.0081
844 DRUG RESISTANCE 207 0.0081
845 BLOOD ALKALINE PHOSPHATASE INCREASED 200 0.0080
846 SEIZURE 925 0.0080
847 DEPRESSION 1815 0.0080
848 OSTEOARTHRITIS 338 0.0080
849 HEPATITIS 202 0.0079
850 DISTURBANCE IN ATTENTION 422 0.0078
851 SWOLLEN TONGUE 244 0.0078
852 THYROID CANCER 94 0.0078
853 DISEASE RECURRENCE 370 0.0078
854 VISUAL ACUITY REDUCED 257 0.0077
855 HYPERTHYROIDISM 111 0.0077
856 PROTEINURIA 145 0.0076
857 COAGULOPATHY 127 0.0076
858 METASTASES TO BONE 125 0.0076
859 THROAT IRRITATION 341 0.0076
860 OXYGEN SATURATION DECREASED 427 0.0076
861 MELAENA 167 0.0076
862 PANCREATITIS 400 0.0076
863 EYE PRURITUS 254 0.0076
864 CHOLESTASIS 145 0.0075
865 ASCITES 221 0.0075
866 LEUKOCYTOSIS 136 0.0075
867 HALLUCINATION 565 0.0075
868 HEPATOCELLULAR INJURY 106 0.0075
869 TRANSAMINASES INCREASED 166 0.0075
870 TACHYCARDIA 661 0.0074
871 HAEMATEMESIS 187 0.0074
872 ALTERED STATE OF CONSCIOUSNESS 159 0.0073
873 PALPITATIONS 848 0.0072
874 BEDRIDDEN 95 0.0072
875 TACHYPNOEA 98 0.0072
876 SPEECH DISORDER 376 0.0072
877 ASPARTATE AMINOTRANSFERASE INCREASED 377 0.0071
878 SHOCK 163 0.0071
879 UPPER GASTROINTESTINAL HAEMORRHAGE 118 0.0070
880 PERITONITIS 145 0.0070
881 ERUCTATION 135 0.0070
882 MENTAL DISORDER 301 0.0069
883 SLEEP APNOEA SYNDROME 132 0.0069
884 MOVEMENT DISORDER 222 0.0069
885 TENDONITIS 107 0.0069
886 ANXIETY 1947 0.0068
887 ASTHMA 772 0.0068
888 PAIN OF SKIN 183 0.0068
889 PRODUCT SUBSTITUTION ISSUE 390 0.0068
890 BRONCHOSPASM 96 0.0067
891 TREATMENT FAILURE 557 0.0067
892 RETCHING 143 0.0067
893 BLOOD CHOLESTEROL INCREASED 312 0.0067
894 CHRONIC KIDNEY DISEASE 507 0.0067
895 BONE LOSS 100 0.0066
896 IRRITABILITY 395 0.0066
897 PROSTATE CANCER 528 0.0066
898 POST PROCEDURAL COMPLICATION 126 0.0066
899 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 314 0.0065
900 MOOD SWINGS 206 0.0065
901 PANCREATITIS ACUTE 145 0.0064
902 PHARYNGEAL OEDEMA 99 0.0064
903 UNRESPONSIVE TO STIMULI 166 0.0064
904 DISCOMFORT 392 0.0064
905 DYSARTHRIA 239 0.0063
906 WHEEZING 375 0.0063
907 DRUG INEFFECTIVE 8301 0.0063
908 HEPATIC STEATOSIS 117 0.0063
909 EYE PAIN 352 0.0062
910 RESTLESSNESS 227 0.0062
911 ELECTROCARDIOGRAM QT PROLONGED 222 0.0062
912 SENSORY DISTURBANCE 98 0.0061
913 ABDOMINAL PAIN LOWER 154 0.0061
914 HEMIPARESIS 102 0.0060
915 HEPATIC CIRRHOSIS 113 0.0060
916 DEPRESSED MOOD 313 0.0059
917 MUSCLE TWITCHING 136 0.0059
918 TUBULOINTERSTITIAL NEPHRITIS 110 0.0059
919 PRODUCT AVAILABILITY ISSUE 131 0.0057
920 BREAST CANCER 536 0.0057
921 PELVIC PAIN 102 0.0056
922 LIVER INJURY 137 0.0056
923 PRODUCT PRESCRIBING ERROR 129 0.0054
924 PANCREATIC CARCINOMA 156 0.0054
925 THROAT TIGHTNESS 146 0.0054
926 ANGIOEDEMA 236 0.0053
927 GAMMA-GLUTAMYLTRANSFERASE INCREASED 117 0.0053
928 PHOTOPHOBIA 99 0.0053
929 ILL-DEFINED DISORDER 315 0.0052
930 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 368 0.0052
931 METABOLIC ACIDOSIS 164 0.0051
932 FLUSHING 519 0.0051
933 MOBILITY DECREASED 359 0.0050
934 EXTRA DOSE ADMINISTERED 197 0.0049
935 SKIN IRRITATION 219 0.0048
936 AGITATION 334 0.0045
937 GASTRIC CANCER 115 0.0045
938 ABNORMAL DREAMS 123 0.0045
939 ACCIDENTAL OVERDOSE 162 0.0044
940 CONVULSION 253 0.0044
941 EYE IRRITATION 253 0.0044
942 CONDITION AGGRAVATED 1328 0.0044
943 HYPOGLYCAEMIA 209 0.0043
944 ECZEMA 219 0.0042
945 INJURY 294 0.0042
946 DRUG-INDUCED LIVER INJURY 129 0.0041
947 DEPRESSED LEVEL OF CONSCIOUSNESS 162 0.0041
948 ACNE 310 0.0041
949 RESPIRATORY ARREST 112 0.0041
950 LACTIC ACIDOSIS 131 0.0040
951 COMA 192 0.0040
952 MIGRAINE 377 0.0039
953 EMOTIONAL DISORDER 117 0.0038
954 EPILEPSY 116 0.0038
955 RHABDOMYOLYSIS 158 0.0038
956 GLYCOSYLATED HAEMOGLOBIN INCREASED 95 0.0038
957 PSYCHOTIC DISORDER 111 0.0038
958 NIGHTMARE 130 0.0038
959 PALLOR 102 0.0037
960 VAGINAL HAEMORRHAGE 162 0.0037
961 PANIC ATTACK 133 0.0036
962 ANGER 122 0.0036
963 SKIN BURNING SENSATION 257 0.0036
964 DYSKINESIA 144 0.0035
965 TYPE 2 DIABETES MELLITUS 117 0.0035
966 PRODUCT USE IN UNAPPROVED INDICATION 847 0.0034
967 BLADDER CANCER 199 0.0034
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 180 0.0033
969 ANAPHYLACTIC REACTION 178 0.0032
970 DRUG EFFECT DECREASED 160 0.0030
971 AGGRESSION 140 0.0028
972 SURGERY 160 0.0027
973 DRUG INTERACTION 375 0.0024
974 NO ADVERSE EVENT 428 0.0024
975 MEDICATION ERROR 106 0.0019
976 PRODUCT STORAGE ERROR 165 0.0019
977 INJECTION SITE REACTION 115 0.0017
978 PSORIASIS 192 0.0015
979 SUICIDAL IDEATION 128 0.0014
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 96 0.0013
981 RHEUMATOID ARTHRITIS 149 0.0013
982 INCORRECT DOSE ADMINISTERED 256 0.0011
983 ACCIDENTAL EXPOSURE TO PRODUCT 106 0.0010
984 OVERDOSE 206 0.0010
985 PRODUCT QUALITY ISSUE 115 0.0008
986 INJECTION SITE ERYTHEMA 105 0.0008
987 EMOTIONAL DISTRESS 94 0.0008
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 97 0.0005